The database of 200 million protein-structure predictions now includes homodimers, adding new biological relevance.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results